ROSZET

Peak

ezetimibe; rosuvastatin calcium

NDAORALTABLET
Approved
Mar 2021
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
May 1, 2033
87 months away
Patent Expiry
May 1, 2033

Patent Records (2)

Patent #ExpiryTypeUse Code
10376470
May 1, 2033
Product
U-3095
9763885
May 1, 2033
Product
U-3095
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history